The impact of Mayo v Prometheus

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

On March 20 2012 the US Supreme Court issued a surprisingly unanimous decision in Mayo Collaborative Services v Prometheus Laboratories, Inc, holding that method claims that involved administering a drug to a patient and determining the therapeutic effects were not patentable subject matter.


Unlock unlimited access to all IAM content